{
  "documentMetadata": {
    "title": "Septic Arthritis with Strep. pneumoniae",
    "lastUpdated": "2024-07-30",
    "sourceFile": "Arthritis, Septic, Pneumococcal.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Septic arthritis with Strep. pneumoniae isolated from blood or joint fluid.",
        "Pneumonia present in about half of cases.",
        "More common in children."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Streptococcus pneumoniae"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "procedure",
      "procedureData": {
        "name": "Drainage of infected synovial fluid",
        "notes": "by needle aspiration, arthroscopy, or arthrotomy repeated as needed to remove re-accumulated pus."
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "condition": "Penicillin susceptible organism (MIC ≤2 µg/mL)",
        "components": [
          {
            "drug": "Penicillin G",
            "dose": "2 mU",
            "route": "IV",
            "frequency": "q4h"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "condition": "Penicillin susceptible organism (MIC ≤2 µg/mL)",
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "2g",
            "route": "IV",
            "frequency": "q24h"
          },
          {
            "drug": "Cefotaxime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          }
        ],
        "notes": "where available"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "condition": "Penicillin-resistant or intermediate organism (MIC >2 µg/mL)",
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "2g",
            "route": "IV",
            "frequency": "q24h"
          },
          {
            "drug": "Cefotaxime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          }
        ],
        "notes": "where available"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "condition": "Penicillin-resistant or intermediate organism (MIC >2 µg/mL)",
        "components": [
          {
            "drug": "Vancomycin",
            "dose": "15-20 mg/kg",
            "frequency": "q8-12h"
          }
        ],
        "notes": "may be preferred if penicillin MIC >4 µg/mL"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "components": [
          {
            "drug": "Levofloxacin",
            "dose": "750 mg",
            "frequency": "q24h",
            "route": "po or IV"
          }
        ]
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "components": [
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "frequency": "q12h",
            "route": "po/IV"
          }
        ],
        "notes": "(oral alternative for severely penicillin-allergic patient or multidrug-resistant organism; monitor for bone marrow suppression for duration of therapy > 2 weeks)(not an approved indication)."
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Duration of therapy:",
        "Optimal duration of therapy unclear: 7-10 days of parenteral therapy with step down to an active oral agent for an additional 2-3 weeks based on clinical response is reasonable.",
        "Consider 6 weeks for prosthetic joint infection; prosthetic removal not always necessary, although late post-surgical infection (> 3 months) and rheumatoid arthritis associated with failure (Clin Infect Dis 2017;64:1742)."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "None"
      ]
    }
  ]
}
